FABP4 exacerbates RA

Nature Reviews Rheumatology, Published online: 03 August 2022; doi:10.1038/s41584-022-00824-1The findings of a new study suggest that the adipokine FABP4 promotes multiple pathological changes in rheumatoid arthritis and could represent a new therapeutic target.

https://www.nature.com/articles/s41584-022-00824-1

Source: Nature Reviews Rheumatology - August 3, 2022 Category: Rheumatology Authors: Sarah Onuora Source Type: research

More News: Arthritis | Rheumatoid Arthritis | Rheumatology | Study